Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.6%
- Check13 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference32%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check42 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check49 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.8%
Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.